FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

24574211000001103: Atosiban 6.75mg/0.9ml solution for injection vials (Sun Pharmaceuticals UK Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 25-Jun 2014. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
79946001000001117 Atosiban 6.75mg/0.9ml solution for injection vials (Sun Pharmaceuticals UK Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
112444501000001112 Atosiban 6.75mg/0.9ml solution for injection vials (Sun Pharmaceutical Industries Europe B.V.) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Atosiban 6.75mg/0.9ml solution for injection vials (Sun Pharmaceuticals UK Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Atosiban 6.75mg/0.9ml solution for injection vials (Sun Pharmaceuticals UK Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Atosiban 6.75mg/0.9ml solution for injection vials (Sun Pharmaceuticals UK Ltd) Is a Atosiban 7.5mg/mL injection solution 0.9mL vial false Inferred relationship Existential restriction modifier
Atosiban 6.75mg/0.9ml solution for injection vials (Sun Pharmaceuticals UK Ltd) Has active ingredient Atosiban true Inferred relationship Existential restriction modifier
Atosiban 6.75mg/0.9ml solution for injection vials (Sun Pharmaceuticals UK Ltd) Has manufactured dose form Conventional release solution for injection true Inferred relationship Existential restriction modifier
Atosiban 6.75mg/0.9ml solution for injection vials (Sun Pharmaceuticals UK Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Atosiban 6.75mg/0.9ml solution for injection vials (Sun Pharmaceuticals UK Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Atosiban 6.75mg/0.9ml solution for injection vials (Sun Pharmaceuticals UK Ltd) Has specific active ingredient Atosiban acetate true Inferred relationship Existential restriction modifier
Atosiban 6.75mg/0.9ml solution for injection vials (Sun Pharmaceuticals UK Ltd) Has dispensed dose form Conventional release solution for injection true Inferred relationship Existential restriction modifier
Atosiban 6.75mg/0.9ml solution for injection vials (Sun Pharmaceuticals UK Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Atosiban true Inferred relationship Existential restriction modifier
Atosiban 6.75mg/0.9ml solution for injection vials (Sun Pharmaceuticals UK Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Atosiban 6.75mg/0.9ml solution for injection vials (Sun Pharmaceuticals UK Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Atosiban 6.75mg/0.9ml solution for injection vials (Sun Pharmaceuticals UK Ltd) Has basis of strength substance Atosiban true Inferred relationship Existential restriction modifier
Atosiban 6.75mg/0.9ml solution for injection vials (Sun Pharmaceuticals UK Ltd) Is a Atosiban 6.75mg/0.9ml solution for injection vials false Inferred relationship Existential restriction modifier
Atosiban 6.75mg/0.9ml solution for injection vials (Sun Pharmaceuticals UK Ltd) Is a Atosiban 6.75mg/0.9ml solution for injection vials true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Atosiban 6.75mg/0.9ml solution for injection vials (Sun Pharmaceuticals UK Ltd) 1 vial Has AMP True Atosiban 6.75mg/0.9ml solution for injection vials (Sun Pharmaceuticals UK Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start